366805-10-9

Upstream product

• 139629-59-7 1-O-allyl-2-deoxy-4,6-isopropylidene-2-(trifluoroacetamido)-α-D-glucopyranoside 
• 132832-52-1 Allyl 2-<(3R)-3-(benzyloxy)tetradecanamido>-3-O-<(3R)-3-(benzyloxy)tetradecanyl>-2-deoxy-4,6-O-isopropylidene-α-D-glucopyranoside 
• 132791-92-5 Allyl 3-O-<(3R)-3-benzyloxytetradecanyl>-2-deoxy-4,6-O-isopropylidene-2-trifluoroacetamido-α-D-glucopyranoside 
• 137119-93-8 (R)-3-benzyloxy-1-(methanesulfonyloxy)tetradecane 

Downstream Products

• 366805-11-0 [(4aR,6S,7R,8R,8aS)-7-((R)-3-Benzyloxy-tetradecanoylamino)-8-((R)-3-benzyloxy-tetradecyloxy)-2,2-dimethyl-hexahydro-pyrano[3,2-d][1,3]dioxin-6-yloxy]-acetic acid 
• 366805-12-1 (diphenylmethoxycarbonyl)methyl 2-[(R)-3-(benzyloxy)tetradecanamido]-3-O-[(R)-3-(benzyloxy)tetradecyl]-2-deoxy-α-D-glucopyranoside 
• 366805-09-6 (diphenylmethoxycarbonyl)methyl 2-[(R)-3-(benzyloxy)tetradecanamido]-3-O-[(R)-3-(benzyloxy)tetradecyl]-2-deoxy-4,6-O-isopropylidene-α-D-glucopyranoside 

Relevant academic research and scientific papers

Synthesis of lipid A type carboxymethyl derivatives with ether chains instead of ester chains and their LPS-antagonistic activities

Synthesis of lipid A type carboxymethyl derivatives having ether chains at both the C-3 and C-3′ positions and their LPS-antagonistic activities toward human U937 cells are described.